tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

WAVE Life Sciences Ltd

WVE
Add to Watchlist
5.510USD
-0.250-4.34%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.09BMarket Cap
LossP/E TTM

WAVE Life Sciences Ltd

5.510
-0.250-4.34%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

WVE Financials

See WAVE Life Sciences Ltd's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

WAVE Life Sciences Ltd Earnings Date

Latest Release
Jul 30, 2026
EPS / Forecast
-0.34/-0.31
Revenue / Forecast
2.27M/7.05M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
42.73M
-60.55%
EPS(YoY)
-1.21
-72.74%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
-10.46%-0.34
54.81%-0.13
-263.05%-0.29
31.11%-0.32
-21.08%-0.31
-18.15%-0.29
223.31%0.18
-806.44%-0.47
-27.02%-0.25
9.09%-0.24
68.40%-0.15
--0.07
---0.20
---0.27
---0.46
---1.60
----
----
----
----
Revenue
-73.88%2.27M
316.85%38.25M
-79.41%17.25M
199.11%7.61M
-55.82%8.70M
-26.82%9.18M
188.23%83.75M
-115.60%-7.68M
-10.92%19.69M
-3.02%12.54M
2245.12%29.06M
17168.07%49.21M
5794.93%22.11M
638.80%12.93M
-29.80%1.24M
-99.22%285.00K
-86.49%375.00K
--1.75M
-81.30%1.77M
955.74%36.42M
Net Profit
-37.42%-69.36M
44.35%-26.09M
-281.79%-53.18M
12.83%-53.85M
-53.29%-50.47M
-48.55%-46.88M
279.95%29.25M
-983.20%-61.78M
-56.00%-32.92M
-15.15%-31.56M
62.81%-16.26M
117.93%7.00M
48.90%-21.10M
27.53%-27.41M
-25.65%-43.71M
-526.07%-39.00M
-6.53%-41.30M
10.95%-37.81M
-20.83%-34.78M
81.18%-6.23M
Net Margin
-426.16%-3052.60%
86.65%-68.21%
-982.84%-308.37%
---707.83%
-247.01%-580.17%
-102.99%-510.93%
162.43%34.93%
----
-75.13%-167.19%
-18.75%-251.70%
98.41%-55.95%
--14.74%
---95.47%
---211.97%
---3527.76%
---4901.00%
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
----
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
Income Statement
Revenue
-73.88%2.27M
316.85%38.25M
-79.41%17.25M
199.11%7.61M
-55.82%8.70M
-26.82%9.18M
188.23%83.75M
-115.60%-7.68M
-10.92%19.69M
-3.02%12.54M
2245.12%29.06M
17168.07%49.21M
5794.93%22.11M
638.80%12.93M
-29.80%1.24M
-99.22%285.00K
-86.49%375.00K
--1.75M
-81.30%1.77M
955.74%36.42M
Operating profit
-39.89%-73.80M
37.16%-31.30M
-345.86%-56.47M
11.83%-56.35M
-50.75%-52.76M
-44.54%-49.80M
222.94%22.97M
-1538.23%-63.91M
-49.09%-35.00M
-13.78%-34.46M
57.11%-18.68M
111.42%4.44M
44.33%-23.47M
20.50%-30.29M
-20.64%-43.56M
-411.36%-38.90M
-5.87%-42.16M
12.37%-38.09M
-19.12%-36.11M
77.90%-7.61M
Net Profit
-37.42%-69.36M
44.35%-26.09M
-281.79%-53.18M
12.83%-53.85M
-53.29%-50.47M
-48.55%-46.88M
279.95%29.25M
-983.20%-61.78M
-56.00%-32.92M
-15.15%-31.56M
62.81%-16.26M
117.93%7.00M
48.90%-21.10M
27.53%-27.41M
-25.65%-43.71M
-526.07%-39.00M
-6.53%-41.30M
10.95%-37.81M
-20.83%-34.78M
81.18%-6.23M
Balance Sheet
Current assets
127.02%507.51M
117.57%561.27M
91.89%614.81M
-33.60%215.49M
29.92%223.56M
31.11%257.98M
36.12%320.39M
104.65%324.51M
-6.84%172.07M
-10.39%196.77M
138.87%235.37M
20.65%158.57M
15.36%184.71M
76.54%219.59M
-39.39%98.54M
-16.81%131.43M
0.43%160.11M
-36.06%124.38M
-29.33%162.56M
-38.87%157.99M
Total current liabilities
-41.86%50.81M
-42.96%49.83M
-14.32%95.06M
-49.69%85.90M
-49.51%87.41M
-47.33%87.37M
-40.49%110.95M
70.76%170.73M
23.46%173.13M
25.12%165.87M
160.68%186.44M
55.59%99.98M
118.82%140.23M
126.66%132.57M
11.40%71.52M
103.09%64.26M
37.16%64.08M
20.14%58.49M
-46.96%64.20M
-71.15%31.64M
Total assets
121.24%558.32M
102.38%583.54M
81.29%638.50M
-32.67%241.38M
20.85%252.35M
22.56%288.34M
28.10%352.21M
79.33%358.50M
-9.20%208.82M
-11.97%235.27M
87.82%274.95M
10.14%199.92M
7.81%229.99M
59.70%267.27M
-29.28%146.39M
-9.48%181.51M
3.35%213.32M
-31.03%167.36M
-25.87%207.01M
-35.33%200.51M
Total liabilities
-0.39%104.80M
-33.91%71.81M
-16.73%112.27M
-47.87%108.95M
-48.53%105.22M
-46.21%108.67M
-40.73%134.82M
-10.12%208.99M
-25.35%204.42M
-31.32%202.01M
23.88%227.44M
30.52%232.53M
56.93%273.83M
84.35%294.11M
10.18%183.60M
9.47%178.16M
-1.24%174.50M
-12.32%159.54M
-11.64%166.63M
-16.09%162.74M
Total equity
208.22%453.52M
184.81%511.73M
142.07%526.23M
-11.43%132.42M
3246.37%147.14M
440.17%179.68M
357.62%217.39M
558.46%149.51M
110.03%4.40M
223.93%33.26M
227.64%47.50M
-1072.04%-32.61M
-212.94%-43.85M
-443.18%-26.84M
-192.19%-37.22M
-91.12%3.35M
30.64%38.82M
-87.11%7.82M
-55.46%40.37M
-67.47%37.77M
Cash Flow Statement
Net operating income
-16.45%-53.58M
5.53%-59.55M
22.62%-33.78M
3.90%-44.67M
-67.51%-46.01M
-88.56%-63.04M
-31.32%-43.65M
-34.89%-46.48M
26.27%-27.47M
-139.09%-33.43M
0.60%-33.24M
-34.36%-34.46M
-29.27%-37.26M
314.49%85.52M
-375.47%-33.44M
9.01%-25.65M
-206.58%-28.82M
10.15%-39.87M
77.61%-7.03M
-39.72%-28.18M
Net investment
-40244.44%-123.45M
-165.45%-438.00K
101.16%1.00K
35.25%-248.00K
-488.46%-306.00K
60.43%-165.00K
75.84%-86.00K
-93.43%-383.00K
27.78%-52.00K
14.72%-417.00K
-101.43%-356.00K
60.48%-198.00K
-100.29%-72.00K
99.03%-489.00K
165700.00%24.84M
-411.22%-501.00K
7360.77%24.61M
-46388.89%-50.21M
97.31%-15.00K
-50.77%-98.00K
Net financing
-97.18%330.00K
-39.18%2.53M
1156.95%439.69M
-83.95%32.69M
1690.66%11.69M
-71.36%4.16M
-62.77%34.98M
12100.36%203.75M
-64.68%653.00K
-58.61%14.51M
170740.00%93.96M
9723.53%1.67M
-97.19%1.85M
2563.60%35.05M
-99.84%55.00K
-99.80%17.00K
1204.26%65.80M
-84.77%1.32M
177757.89%33.79M
-94.14%8.35M

FAQs

What is the total revenue of WAVE Life Sciences Ltd?

According to WAVE Life Sciences Ltd's FY2025 earnings report, its total revenue reached 42.73M, with a year-on-year change of 108.30M.

What are the current assets of WAVE Life Sciences Ltd?

According to WAVE Life Sciences Ltd's FY2025 earnings report, its current assets were 614.81M, with a year-on-year change of 91.89.

What are the total assets of WAVE Life Sciences Ltd?

According to WAVE Life Sciences Ltd's FY2025 earnings report, its total assets of WAVE Life Sciences Ltd were 638.50M, with a year-on-year change of 81.29.

What are the total liabilities of WAVE Life Sciences Ltd?

According to WAVE Life Sciences Ltd's FY2025 earnings report, its total liabilities of WAVE Life Sciences Ltd were 112.27M, with a year-on-year change of -16.73.

What is the total equity of WAVE Life Sciences Ltd?

According to WAVE Life Sciences Ltd's FY2025 earnings report, its total equity of WAVE Life Sciences Ltd was 526.23M, with a year-on-year change of 142.07.

What is the net operating income of WAVE Life Sciences Ltd?

According to WAVE Life Sciences Ltd's FY2025 earnings report, its net operating income of WAVE Life Sciences Ltd was -215.38M, with a year-on-year change of -95.09.

What is the net investment of WAVE Life Sciences Ltd?

According to WAVE Life Sciences Ltd's FY2025 earnings report, its net investment of WAVE Life Sciences Ltd was -718.00K, with a year-on-year change of 23.45.

What is the net financing of WAVE Life Sciences Ltd?

According to WAVE Life Sciences Ltd's FY2025 earnings report, its net financing of WAVE Life Sciences Ltd was 488.24M, with a year-on-year change of 92.30.

What is the Earnings Per Share (EPS) of WAVE Life Sciences Ltd?

According to WAVE Life Sciences Ltd's FY2025 earnings report, its Earnings Per Share (EPS) was -1.21, with a year-on-year change of -72.74.

What is the net income of WAVE Life Sciences Ltd?

According to WAVE Life Sciences Ltd's FY2025 earnings report, its net income was -204.38M, with a year-on-year change of -110.68.

What is the net margin of WAVE Life Sciences Ltd?

According to WAVE Life Sciences Ltd's FY2025 earnings report, its net profit margin was -478.33, with a year-on-year change of -434.02.

What is the Return on Equity (ROE) of WAVE Life Sciences Ltd?

According to WAVE Life Sciences Ltd's FY2025 earnings report, its Return on Equity (ROE) was -56.16, with a year-on-year change of 27.89.

What is the Return on Assets (ROA) of WAVE Life Sciences Ltd?

According to WAVE Life Sciences Ltd's FY2025 earnings report, its Return on Assets (ROA) was -41.26, with a year-on-year change of -33.37.

What is the operating profit of WAVE Life Sciences Ltd?

According to WAVE Life Sciences Ltd's FY2025 earnings report, its operating profit was -215.38M, with a year-on-year change of -95.09.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy